GPT and metabolic dysfunction-associated steatotic liver disease: Among readily available non-invasive tests such as AST/ALT ratio, AST to platelet ratio index (APRI), NAFLD fibrosis score (NFS), the FIB-4 index has the best performance, with an AUROC of 0.62–0.80 for the prediction of advanced liver fibrosis (≥F3) [22].